Stock 6730 LAGIS ENTERPRISE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Lagis Enterprise Co., Ltd.

Equities

6730

TW0006730005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 02/07/2024 am IST 		5-day change 1st Jan Change
40.55 TWD +1.37% Intraday chart for Lagis Enterprise Co., Ltd. +3.97% +6.71%
26/04 Lagis Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lagis Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 1,920 1,107 1,062 1,035 1,216
Enterprise Value (EV) 1 1,773 994.9 921.8 915.7 1,304
P/E ratio 21.1 x 34.3 x 21.8 x 14.8 x 19.2 x
Yield 2.38% 2.31% 3.01% 5.56% 2.63%
Capitalization / Revenue 4.72 x 3.47 x 2.7 x 2.34 x 2.64 x
EV / Revenue 4.36 x 3.12 x 2.35 x 2.07 x 2.83 x
EV / EBITDA 13 x 14.7 x 10.5 x 8.78 x 13.1 x
EV / FCF 20.4 x 103 x 17 x -142 x -9.37 x
FCF Yield 4.91% 0.97% 5.89% -0.7% -10.7%
Price to Book 3.96 x 2.35 x 2.15 x 1.94 x 2.25 x
Nbr of stocks (in thousands) 32,001 32,001 32,001 32,001 32,001
Reference price 2 60.00 34.60 33.20 32.35 38.00
Announcement Date 16/04/20 23/04/21 21/04/22 21/04/23 26/04/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 398.8 406.5 319.4 393 442.2 459.9
EBITDA 1 129.8 136.5 67.71 87.88 104.3 99.63
EBIT 1 104.7 112.3 44.61 64.82 81.68 77.1
Operating Margin 26.24% 27.63% 13.97% 16.49% 18.47% 16.76%
Earnings before Tax (EBT) 1 107 111.5 40.4 61.18 88.59 80.13
Net income 1 85.89 89.16 32.32 48.94 71.04 64.1
Net margin 21.54% 21.93% 10.12% 12.45% 16.06% 13.94%
EPS 2 2.719 2.848 1.010 1.520 2.180 1.980
Free Cash Flow 1 73.04 86.98 9.628 54.25 -6.437 -139.1
FCF margin 18.31% 21.4% 3.01% 13.8% -1.46% -30.25%
FCF Conversion (EBITDA) 56.27% 63.72% 14.22% 61.74% - -
FCF Conversion (Net income) 85.03% 97.56% 29.79% 110.86% - -
Dividend per Share 2 1.636 1.429 0.8000 1.000 1.800 1.000
Announcement Date 06/06/19 16/04/20 23/04/21 21/04/22 21/04/23 26/04/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 87.8
Net Cash position 1 57 147 112 141 119 -
Leverage (Debt/EBITDA) - - - - - 0.881 x
Free Cash Flow 1 73 87 9.63 54.3 -6.44 -139
ROE (net income / shareholders' equity) 22.8% 20.2% 6.75% 10.1% 13.8% 11.9%
ROA (Net income/ Total Assets) 13.1% 12.7% 4.95% 7.16% 8.15% 6.41%
Assets 1 658 700 652.4 683.8 871.6 1,000
Book Value Per Share 2 12.90 15.20 14.70 15.50 16.70 16.90
Cash Flow per Share 2 2.500 4.710 3.590 4.710 4.020 2.810
Capex 1 23.9 10.5 14.8 26.1 65.6 223
Capex / Sales 5.99% 2.59% 4.63% 6.65% 14.83% 48.4%
Announcement Date 06/06/19 16/04/20 23/04/21 21/04/22 21/04/23 26/04/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
LAGIS ENTERPRISE CO., LTD. Stock Lagis Enterprise Co., Ltd.
+6.71% 39.28M
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.24% 180B
MEDTRONIC PLC Stock Medtronic plc
-6.08% 98.89B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.98% 66.26B
DEXCOM, INC. Stock DexCom, Inc.
-9.35% 44.61B
CENCORA, INC. Stock Cencora, Inc.
+8.34% 44.02B
HOYA CORPORATION Stock Hoya Corporation
+10.13% 40.12B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+11.88% 29.19B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.38% 23.64B
TERUMO CORPORATION Stock Terumo Corporation
+13.33% 23.41B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6730 Stock
  4. Financials Lagis Enterprise Co., Ltd.